People
21 August 2019 - Provention Bio Inc (Nasdaq: PRVB), a clinical stage biopharmaceutical company involved in intercepting and preventing immune-mediated diseases, announced yesterday that it has named S...
20 August 2019 - The United States Food and Drug Administration (FDA) has approved United States-based Celgene's Inrebic (fedratinib) intended to treat adult patients with intermediate-two or hig...
20 August 2019 - Xynomic Research Institute (XRI), a subsidiary of Xynomic Pharmaceuticals Holdings, has designed a series of potent RET kinase inhibitors by computer-assisted drug design, it was repo...
19 August 2019 - - US-based biopharmaceutical company Bioasis Technology Inc (OTCQB: BIOAF) (TSX.V: BTI) has appointed Caroline Dircks, Ph.D., as chief operating officer, the company said.

16 August 2019 - - US-based neuroscience disease treatements developer Cerevel Therapeutics has appointed Orly Mishan as chief business officer, the company said.

In this newly ...
16 August 2019 - Marker Therapeutics Inc (Nasdaq:MRKR), a clinical-stage immuno-oncology company specialising in the development of next-generation T cell-based immunotherapies for the treatment of ha...